Skip to main content
Clinical Trials/NCT03655860
NCT03655860WithdrawnNot Applicable

Evaluation of SIMEOX on Flow and Volume Elicited in Healthy Subjects

Cliniques universitaires Saint-Luc- Université Catholique de Louvain2 sites in 1 countryStarted: September 15, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
2
Primary Endpoint
Change in expiratory volume

Study Overview

Brief Summary

This study will investigate the effects of the SIMEOX (an airway clearance device) on flow and volume generated in healthy subjects

Detailed Description

This is a pilot study assessing the effect of the SIMEOX device on flow and volume generated in healthy subjects.

Assessment of flow and volume will be performed before and during the application of the SIMEOX. Vital capacity and expiratory flow will be assessed.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Able to understand the instructions

Exclusion Criteria

  • Obesity (BMI > 30kg/m²)
  • Active smoker
  • Severe scoliosis
  • Cardiovascular ou neuromuscular disease

Outcomes

Primary Outcomes

Change in expiratory volume

Time Frame: 5min

Expiratory volume before and during the use of the SIMEOX will be compared

Change in expiratory volume flow rate

Time Frame: 5min

Expiratory flow rate before and during the use of the SIMEOX will be compared

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials